Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00170292
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
177 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]- PYRROLIDINE-3-CARBOXYLIC ACID 5- CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)- BENZYLAMIDE | A,B | 1TA6 | 0.71 |  |
RPF | 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]- PHENYL}-6-(1,2,,3,4-TETRAHYDRO- QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN- 2-ONE | A,B | 2BKT | 0.7 | |
G05 | (4aR,6r,7aS)-hexahydro-4aH-cyclopenta[b][1,4]dioxin- 6-yl [(1S,2R)-1-benzyl-2-hydroxy- 3-{[(4-methoxyphenyl)sulfonyl](2- methylpropyl)amino}propyl]carbamate | A,B | 3DK1 | 0.75 | |
HBH | 2-[(8S,11S)-11-{(1R)-1-HYDROXY- 2-[ISOPENTYL(PHENYLSULFONYL)AMINO]ETHYL}- 6,9-DIOXO-2-OXA-7,10-DIAZABICYCLO[11.2.2]HEPTADECA- 1(15),13,16-TRIEN-8-YL]ACETAMIDE | A,B | 1Z1R | 0.76 | |
C4M | N-[(2R,3S)-3-AMINO-2-HYDROXY-4- PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE | B,I | 2C93 | 0.73 | |
MUI | (5S)-3-(4-ACETYLPHENYL)-N-[(1S,2R)- 1-BENZYL-2-HYDROXY-3-{ISOBUTYL[(4- METHOXYPHENYL)SULFONYL]AMINO}PROPYL]- 2-OXO-1,3-OXAZOLIDINE-5-CARBOXAMIDE | A,B | 2I0A | 0.71 | |
HA2 | 6-[{(2S)-2-AMINO-3-[4-(BENZYLOXY)PHENYL]PROPYL}(HYDROXY)AMINO]- 6-OXOHEXANOIC ACID) | A | 2VJ8 | 0.7 | |
997 | 1-[3,3-DIMETHYL-2-(2-METHYLAMINO- PROPIONYLAMINO)-BUTYRYL]-4-PHENOXY- PYRROLIDINE-2-CARBOXYLIC ACID(1,2,3,4- TETRAHYDRO-NAPHTHALEN-1-YL)-AMIDE | A | 1TFT | 0.76 | |
MZ3 | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(3-METHOXYPHENYL)SULFONYL](2- THIENYLMETHYL)AMINO}PROPYL]-3-FLUORO- 2-METHYLBENZAMIDE | A,B | 2QI0 | 0.71 | |
11N | 1-[1'-(3-phenylacryloyl)spiro[1- benzofuran-3,4'-piperidin]-5-yl]methanamine | A,B,C,D | 2ZEC | 0.72 | |
C5M | N-{(2R,3S)-3-[(3-CHLOROBENZYL)AMINO]- 2-HYDROXY-4-PHENYLBUTYL}-4-METHOXY- 2,3,6-TRIMETHYLBENZENESULFONAMIDE | B,I | 2C8X | 0.73 | |
32P | 3-{2-[(5-AMINOPENTYL)AMINO]-2-OXOETHOXY}- 5-({[1-(4-FLUOROPHENYL)ETHYL]AMINO}CARBONYL)PHENYL PHENYLMETHANESULFONATE | A | 1TQF | 0.75 | |
BBH | 1-BENZYL-3-(4-METHOXY-BENZENESULFONYL)- 6-OXO-HEXAHYDRO-PYRIMIDINE-4-CARBOXYLIC ACID HYDROXYAMIDE | A,B | 1D8M | 0.79 | |
| BBH | 1-BENZYL-3-(4-METHOXY-BENZENESULFONYL)- 6-OXO-HEXAHYDRO-PYRIMIDINE-4-CARBOXYLIC ACID HYDROXYAMIDE | A,B | 1G05 | 0.79 | |
190 | N-{(1S)-1-(3-BROMOBENZYL)-4-[(4- BROMOPHENYL)SULFONYL]-6-METHYL- 2-OXOHEPTYL}-2-(2,6-DIMETHYLPHENOXY)ACETAMIDE | A,B | 1XL5 | 0.72 | |
LK1 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- L-GLUTAMIC ACID | A | 2JFH | 0.71 | |
MDW | (1R)-N,6-DIHYDROXY-7-METHOXY-2- [(4-METHOXYPHENYL)SULFONYL]-1,2,3,4- TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE | A | 2DDY | 0.74 | |
SPI | N-HYDROXY-1-(4-METHOXYPHENYL)SULFONYL- 4-BENZYLOXYCARBONYL-PIPERAZINE- 2-CARBOXAMIDE | A,B | 1D8F | 0.77 | |
006 | (4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}- 2-hydroxy-4-phenylbutanoyl]-N-[(1S,2R)- 2-hydroxy-2,3-dihydro-1H-inden- 1-yl]-5,5-dimethyl-1,3-thiazolidine- 4-carboxamide | A,B,C,D | 3FNU | 0.71 | |
PI9 | A,B | 1D4L | 0.75 | | |
CCR | [N-[N-(4-METHOXY-2,3,6-TRIMETHYLPHENYLSULFONYL)- L-ASPARTYL]-D-(4-AMIDINO-PHENYLALANYL)]- PIPERIDINE | A | 1K1N | 0.7 | |
| CCR | [N-[N-(4-METHOXY-2,3,6-TRIMETHYLPHENYLSULFONYL)- L-ASPARTYL]-D-(4-AMIDINO-PHENYLALANYL)]- PIPERIDINE | H,I | 1YPK | 0.7 | |
AGG | TIROFIBAN | A,B | 2VDM | 0.73 | |
AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2Q5K | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2QHC | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2RKF | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | B | 1MUI | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | B | 1RV7 | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2RKG | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2O4S | 0.71 | |
| AB1 | N-{1-BENZYL-4-[2-(2,6-DIMETHYL- PHENOXY)-ACETYLAMINO]-3-HYDROXY- 5-PHENYL-PENTYL}-3-METHYL-2-(2- OXO-TETRAHYDRO-PYRIMIDIN-1-YL)- BUTYRAMIDE | A,B | 2Z54 | 0.71 | |
4NH | 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)- N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE- 3-CARBOXAMIDE | A,B | 2A8H | 0.72 | |
LK2 | N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]- D-GLUTAMIC ACID | A | 2JFF | 0.71 | |
DJR | (3R,3AS,6AR)-HEXAHYDROFURO[2,3- B]FURAN-3-YL [(1S,2R)-1-BENZYL- 2-HYDROXY-3-{ISOBUTYL[(4-METHOXYPHENYL)SULFONYL]AMINO}PROPYL]CARBAMATE | A | 2I4U | 0.71 | |
| DJR | (3R,3AS,6AR)-HEXAHYDROFURO[2,3- B]FURAN-3-YL [(1S,2R)-1-BENZYL- 2-HYDROXY-3-{ISOBUTYL[(4-METHOXYPHENYL)SULFONYL]AMINO}PROPYL]CARBAMATE | B | 2I4V | 0.71 | |
IH6 | (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}- N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE- 3-CARBOXAMIDE | A,B | 1ZXC | 0.71 | |
MO9 | (1R)-2-[(CYANOMETHYL)AMINO]-1-({[2- (DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)- 2-OXOETHYL MORPHOLINE-4-CARBOXYLATE | A,B | 2G7Y | 0.73 | |
F1N | N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin- 4-yl}-2-(2-methyl-4-sulfamoylphenoxy)acetamide | A | 2ZJN | 0.81 | |
NOQ | (1R,2R)-N-(2-AMINOETHYL)-2-{[(4- METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE | A | 2F7D | 0.72 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HHN | 0.72 | |
| GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HH5 | 0.72 | |
189 | N-BENZYL-2-(2,6-DIMETHYLPHENOXY)- N-[((3R,4S)-4-{[ISOBUTYL(PHENYLSULFONYL)AMINO]METHYL}PYRROLIDIN- 3-YL)METHYL]ACETAMIDE | A,B | 1XL2 | 0.85 | |
HBB | N-{(2R)-2-HYDROXY-2-[(8S,11S)-8- ISOPROPYL-6,9-DIOXO-2-OXA-7,10- DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16- TRIEN-11-YL]ETHYL}-N-ISOPENTYLBENZENESULFONAMIDE | A,B | 1Z1H | 0.78 | |
F1I | N-[1-(2,6-dimethoxybenzyl)piperidin- 4-yl]-4-sulfanylbutanamide | A | 2ZJI | 0.72 | |
MUV | N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2- FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}- N'-METHYLSUCCINAMIDE | A,B | 2PSV | 0.74 | |
MUT | (5S)-3-(3-ACETYLPHENYL)-N-[(1S,2R)- 1-BENZYL-2-HYDROXY-3-{ISOBUTYL[(4- METHOXYPHENYL)SULFONYL]AMINO}PROPYL]- 2-OXO-1,3-OXAZOLIDINE-5-CARBOXAMIDE | A,B | 2I0D | 0.71 | |
F1M | N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin- 4-yl}-2-(4-sulfamoylphenoxy)acetamide | A | 2ZJM | 0.81 | |
MUU | N-[(1S,2R)-1-BENZYL-3-{(CYCLOPROPYLMETHYL)[(3- METHOXYPHENYL)SULFONYL]AMINO}-2- HYDROXYPROPYL]-N'-METHYLSUCCINAMIDE | A,B | 2PSU | 0.77 | |
MBS | A,B | 1HY7 | 0.7 | | |
LK3 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}- D-GLUTAMIC ACID | A | 2UUO | 0.71 | |
K21 | 4-[3-{1-(4-BENZYL)PIPERODINYL}PROPIONYL]- 7-METHOXY-2,3,4,5-TERTRAHYDRO-1,4- BENZOTHIAZEPINE | A,B | 1HAK | 0.72 | |
MZ9 | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(4-METHOXYPHENYL)SULFONYL][(2S)- 2-METHYLBUTYL]AMINO}PROPYL]-4-OXOHEXANAMIDE | A,B | 2QI7 | 0.78 | |
G55 | (5R)-1,3-dioxepan-5-yl [(1S,2R)- 1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2- methylpropyl)amino}propyl]carbamate | A,B | 3DJK | 0.73 | |
LIJ | BENZYL [(1S)-2-({(1S,2R)-1-BENZYL- 2-HYDROXY-3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)- 2-OXO-1-{[(1-PROPYLBUTYL)SULFONYL]METHYL}ETHYL]CARBAMATE | A,B,C | 2HIZ | 0.72 | |